checkAd

     153  0 Kommentare Positron Corporation Announces Attrius PET System Sale

    Niagara Falls, NY, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET imaging systems and clinical services, is pleased to welcome a prominent cardiovascular practice in Pennsylvania as a new customer utilizing Positron’s Attrius PET System and services. Positron will install the Attrius in the coming months concurrent with the facility’s radiopharmaceutical timeline. 

    Positron is the only company in the industry offering a dedicated PET scanner optimized for nuclear cardiology. The Attrius is a 2D quantitative PET scanner that provides robust high-resolution images that complements coronary flow reserve software to produce accurate measurements of absolute blood flow.

    Positron’s new Attrius customer will take advantage of the Company’s Lease to Own & Services Program which provides  a complete package of Attrius PET System and the full scope Clinical & Technical Services for one monthly price for five years. Positron’s Lease to Own Program has zero upfront capex expense and provides the most viable operational model for nuclear imaging practices seeking the PET modality. Positron is working with several parties interested in its Attrius dedicated PET and expects to enter additional lease to own/services agreements upon customers completion of site preparation and  radiopharmaceutical supply agreements.   

    Adel Abdullah, President of Positron stated, “We are pleased to be part of our customers evolution from SPECT to cardiac PET imaging. Our Attrius PET is a tremendous tool for advanced cardiac studies and diagnostics, and we are excited for our customers to take full advantage of the capabilities of our Attrius PET, services, training, and innovative new lease to own program. Our objectives are fully in-line with our physicians and practices in providing  the best quality medical care,  which we achieve through Positron’s PET technology and equally important clinical services and all at a favorable price point. Our clinical team provides expert training and assistance necessary to assure that our customers receive the full benefits of the Attrius PET system and quantification software. Positron’s Attrius dedicated PET system and services provides nuclear imaging practices the best value through the combination of high technology and  cost-effective imaging solutions.

    Seite 1 von 2



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Positron Corporation Announces Attrius PET System Sale Niagara Falls, NY, Nov. 24, 2023 (GLOBE NEWSWIRE) - Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET imaging systems and clinical services, is pleased to welcome a …